Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G/A - MoonLake Immunotherapeutics | StockGist | StockGist

Companies
MLTX
SCHEDULE 13G/A

Home Top Movers Companies Concepts

Home Filings MLTXSCHEDULE 13G/A

SCHEDULE 13G/A

Beneficial Ownership

Amendment

MoonLake Immunotherapeutics

Filed Feb 12, 2025

Accepted Feb 11, 2025, 7:00 PM ET

CIK 0001821586

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

49.00%

Shares Owned

315,066

Reporting Person

MoonLake Immunotherapeutics

Person Type

HC

CUSIP: 61559X104

Amendment History

5 filings

SCHEDULE 13G
Original
Nov 12, 20250001172661-25-004733
SCHEDULE 13G/A
Amendment 1
Viewing
Feb 12, 20250000315066-25-000896
SCHEDULE 13G/A
Amendment 2
May 14, 20250000080255-25-000373
SCHEDULE 13G/A
Amendment 3
Aug 6, 20250000315066-25-002044
SCHEDULE 13G/A
Amendment 4
Latest
Nov 14, 20250000902664-25-004943

Key Facts

% of Class

49.00%

Shares Owned

315,066

Recent Filings

MoonLake Immunotherapeutics2 days ago

MoonLake Immunotherapeutics1 months ago

MoonLake Immunotherapeutics1 months ago

MoonLake Immunotherapeutics1 months ago

MoonLake Immunotherapeutics2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice